Close Menu

NEW YORK – HTG Molecular has completed a 1-for-15 reverse stock split of its outstanding common stock.

As a result of the split, effective with the open of the market on Monday, the firm's common stock is now trading on a split-adjusted basis.

Authorization for the reverse split was approved by the firm's stockholders at HTG's annual stockholder meeting in August, and subsequently approved by its board of directors last week. The number of authorized shares of common stock will be reduced to 26.7 million from 200 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.